Authors: Dickmann, LJ Rettie, AE Kneller, MB Kim, RB Wood, AJJ Stein, CM Wilkinson, GR Schwarz, UI

Citation: Lj. Dickmann et al., Identification and functional characterization of a new CYP2C9 variant (CYP2C95) expressed among African Americans, MOLEC PHARM, 60(2), 2001, pp. 382-387

Authors: Kim, RB Leake, BF Choo, EF Dresser, GK Kubba, SV Schwarz, UI Taylor, A Xie, HG McKinsey, J Zhou, S Lan, LB Schuetz, JD Schuetz, EG Wilkinson, GR

Citation: Rb. Kim et al., Identification of functionally variant MDR1 alleles among European Americans and African Americans, CLIN PHARM, 70(2), 2001, pp. 189-199

Authors: Schwarz, UI Gramatte, T Krappweis, J Oertel, R Kirch, W

Citation: Ui. Schwarz et al., P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans, INT J CL PH, 38(4), 2000, pp. 161-167

Authors: Schwarz, UI Stoelben, S Ebert, U Siepmann, M Krappweis, J Kirch, W

Citation: Ui. Schwarz et al., Regional drug information service, INT J CL PH, 37(6), 1999, pp. 263-268

Authors: Krappweis, J Rentsch, A Schwarz, UI Krobot, KJ Kirch, W

Citation: J. Krappweis et al., Outpatient costs of osteoporosis in a national health insurance population, CLIN THER, 21(11), 1999, pp. 2001-2014

Authors: Schwarz, UI Gramatte, T Krappweis, J Berndt, A Oertel, R von Richter, O Kirch, W

Citation: Ui. Schwarz et al., Unexpected effect of verapamil on oral bioavailability of the beta-blockertalinolol in humans, CLIN PHARM, 65(3), 1999, pp. 283-290